Bfsg LLC Purchases New Shares in Revvity, Inc. (NYSE:RVTY)

Bfsg LLC acquired a new position in Revvity, Inc. (NYSE:RVTY) in the fourth quarter, HoldingsChannel.com reports. The institutional investor acquired 7,235 shares of the company’s stock, valued at approximately $791,000.

Other hedge funds and other institutional investors have also recently added to or reduced their stakes in the company. Vanguard Group Inc. acquired a new position in shares of Revvity during the 3rd quarter worth approximately $1,579,487,000. Ceredex Value Advisors LLC acquired a new position in shares of Revvity during the 4th quarter worth approximately $108,353,000. Sumitomo Mitsui Trust Holdings Inc. acquired a new position in shares of Revvity during the 4th quarter worth approximately $33,568,000. Boston Trust Walden Corp acquired a new position in shares of Revvity during the 4th quarter worth approximately $25,154,000. Finally, KBC Group NV acquired a new position in Revvity in the 3rd quarter valued at $25,301,000. 86.65% of the stock is currently owned by institutional investors and hedge funds.

Analysts Set New Price Targets

Several research firms have weighed in on RVTY. Stifel Nicolaus increased their price objective on Revvity from $95.00 to $110.00 and gave the stock a “hold” rating in a research report on Friday, February 2nd. KeyCorp raised their price target on Revvity from $110.00 to $126.00 and gave the stock an “overweight” rating in a research report on Friday, February 2nd. Barclays raised their price objective on Revvity from $92.00 to $105.00 and gave the company an “equal weight” rating in a research note on Thursday, January 25th. UBS Group lowered Revvity from a “buy” rating to a “neutral” rating and raised their price objective for the company from $105.00 to $125.00 in a research note on Tuesday, January 16th. Finally, Evercore ISI raised Revvity from an “in-line” rating to an “outperform” rating and raised their price objective for the company from $88.00 to $125.00 in a research note on Thursday, January 4th. Six investment analysts have rated the stock with a hold rating and six have issued a buy rating to the stock. According to MarketBeat, the stock presently has an average rating of “Moderate Buy” and an average target price of $118.91.

Insiders Place Their Bets

In other Revvity news, insider Prahlad R. Singh sold 21,217 shares of the company’s stock in a transaction dated Monday, February 5th. The stock was sold at an average price of $104.28, for a total value of $2,212,508.76. Following the transaction, the insider now directly owns 92,801 shares in the company, valued at approximately $9,677,288.28. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available through this hyperlink. Corporate insiders own 0.60% of the company’s stock.

Revvity Trading Down 0.8 %

RVTY stock traded down $0.82 during mid-day trading on Wednesday, reaching $102.68. The company’s stock had a trading volume of 632,067 shares, compared to its average volume of 853,912. The company has a market cap of $12.68 billion, a price-to-earnings ratio of 18.67, a price-to-earnings-growth ratio of 2.62 and a beta of 1.09. Revvity, Inc. has a 12 month low of $79.50 and a 12 month high of $133.26. The business’s 50 day moving average price is $104.74 and its 200 day moving average price is $101.49. The company has a current ratio of 2.07, a quick ratio of 1.77 and a debt-to-equity ratio of 0.40.

Revvity (NYSE:RVTY) last released its quarterly earnings data on Thursday, February 1st. The company reported $1.25 EPS for the quarter, beating the consensus estimate of $1.15 by $0.10. The firm had revenue of $695.90 million during the quarter. Revvity had a return on equity of 7.41% and a net margin of 25.20%. On average, equities research analysts predict that Revvity, Inc. will post 4.65 EPS for the current year.

Revvity Dividend Announcement

The firm also recently announced a quarterly dividend, which will be paid on Friday, May 10th. Shareholders of record on Friday, April 19th will be paid a $0.07 dividend. The ex-dividend date is Thursday, April 18th. This represents a $0.28 dividend on an annualized basis and a yield of 0.27%. Revvity’s dividend payout ratio is currently 5.09%.

Revvity Company Profile

Revvity, Inc provides health sciences solutions, technologies, and services in the Americas, Europe, and Asia, and internationally. The Life Sciences segment provides instruments, reagents, informatics, software, subscriptions, detection, imaging technologies, warranties, training, and services. Its Diagnostics segment provides instruments, reagents, assay platforms, and software products for the early detection of genetic disorders, such as pregnancy and early childhood, as well as infectious disease testing in the diagnostics market.